DongKoo Bio & Pharma Co. Ltd. (006620) — Working Capital to Net Assets Ratio
DongKoo Bio & Pharma Co. Ltd. (006620) has a Working Capital to Net Assets ratio of -9.4% as of June 2026. Working capital of ₩-13.40 Billion (current assets of ₩117.55 Billion minus current liabilities of ₩130.95 Billion) is measured against net assets of ₩142.58 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See DongKoo Bio & Pharma Co. Ltd. liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
DongKoo Bio & Pharma Co. Ltd. Working Capital to Net Assets (2015–2025)
This chart shows how DongKoo Bio & Pharma Co. Ltd.'s Working Capital to Net Assets ratio has evolved across 11 annual periods from 2015 to 2025. As of June 2026, the ratio stands at -9.4%, reflecting working capital of ₩-13.40 Billion against net assets of ₩142.58 Billion KRW. For the complete balance sheet picture, see 006620 total asset value.
Annual Working Capital to Net Assets for DongKoo Bio & Pharma Co. Ltd. (2015–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for DongKoo Bio & Pharma Co. Ltd. from 2015 to 2025, covering 11 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check DongKoo Bio & Pharma Co. Ltd. (006620) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | -7.3% | ₩-11.17 Billion | ₩152.16 Billion | ₩126.30 Billion | ₩137.47 Billion | ▲ +0.3 pp |
| 2024 | -7.6% | ₩-8.01 Billion | ₩105.33 Billion | ₩107.24 Billion | ₩115.25 Billion | ▼ -21.2 pp |
| 2023 | 13.6% | ₩15.05 Billion | ₩110.44 Billion | ₩88.36 Billion | ₩73.32 Billion | ▼ -7.3 pp |
| 2022 | 20.9% | ₩21.37 Billion | ₩102.11 Billion | ₩87.42 Billion | ₩66.04 Billion | ▼ -2.8 pp |
| 2021 | 23.8% | ₩23.81 Billion | ₩100.12 Billion | ₩73.83 Billion | ₩50.02 Billion | ▼ -9.9 pp |
| 2020 | 33.6% | ₩31.84 Billion | ₩94.65 Billion | ₩72.35 Billion | ₩40.51 Billion | ▼ -5.5 pp |
| 2019 | 39.2% | ₩33.56 Billion | ₩85.65 Billion | ₩71.90 Billion | ₩38.35 Billion | ▼ -2.7 pp |
| 2018 | 41.9% | ₩30.19 Billion | ₩72.10 Billion | ₩58.81 Billion | ₩28.62 Billion | ▲ +15.5 pp |
| 2017 | 26.3% | ₩9.94 Billion | ₩37.74 Billion | ₩44.52 Billion | ₩34.58 Billion | ▲ +57.9 pp |
| 2016 | -31.6% | ₩-6.97 Billion | ₩22.05 Billion | ₩32.18 Billion | ₩39.15 Billion | ▲ +671.0 pp |
| 2015 | -702.6% | ₩-17.92 Billion | ₩2.55 Billion | ₩24.85 Billion | ₩42.77 Billion | — |